Approval · Notice of Compliance 15647 · 2014
QUADRAMET: Notice of Compliance 15647
Issued May 29, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15647
- Date
- May 29, 2014
- Company
- Superna Life Sciences Inc.Vancouver, British Columbia, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer's name
- Therapeutic class
- Therapeutic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QUADRAMET | Not yet assigned | — |
Medicinal ingredients
- SAMARIUM 153SM LEXIDRONAM 50 MCCI per ML